The initial public offerings (IPOs) in the biopharmaceutical sector surged 68.4 per cent to reach $8.52 billion globally in ...

Growing crypto adoption and a favorable regulatory outlook have VCs on the hunt for liquidity events and in 2025 they can ...

Over the past couple weeks, as we’ve seen Klarna, StubHub and others delay scheduled pre-IPO roadshows, it appears markets ...

ChrysCapital Managing Partner Kunal Shroff highlights strengthening exit avenues for private equity firms despite an ...

Tariff uncertainty is putting even more pressure on the VC market, leaving investors hesitant as tech companies postpone IPOs ...

A volatile stock market, trade war uncertainty, and rising recession fears have frozen IPOs and rattled venture capital.

Monday saw more chaos and confusion on Wall Street. The Dow Jones Industrial Average saw trading range from 36,705 to 39,198- a nearly 2,500-point swing after a report indicating Trump could be open ...

A few months ago, after years of abysmal performance, it looked like IPOs were finally set for a comeback. ServiceTitan, a software platform for general contractors, saw its stock soar by 35% ...

The market turbulence unleashed by President Donald Trump’s tariff policies will likely evaporate the trickle of biotech IPOs ...

Some companies planning to list this year, especially those aiming at going public in the first quarter, have delayed their IPOs to as late as early 2026, the report, published Thursday ...